23:04:42 EDT Thu 24 Sep 2020
Enter Symbol
or Name

Login ID:
Microbix Biosystems Inc
Symbol MBX
Shares Issued 108,747,705
Close 2020-05-05 C$ 0.32
Recent Sedar Documents

Globe says Stellick rates Microbix "speculative buy"

2020-05-06 08:35 ET - In the News

The Globe and Mail reports in its Wednesday, May 6, edition that Industrial Alliance Securities analyst Chelsea Stellick believes Microbix Biosystems (32 cents) is "poised to gain global attention as a result of the COVID-19 pandemic where increased testing and the need for quality control will increase the demand for MBX's expertise to develop controls to test for the SARS-CoV-2 virus." The Globe's David Leeder writes in the Eye On Equities column that Ms. Stellick, seeing "ample" upside, began coverage on Microbix with a "speculative buy" rating. Mr. Leeder notes that Ms. Stellick is the lone analyst covering the stock. She set a share target of 50 cents. Ms. Stellick says in a note: "For over 30 years, Microbix has offered an expansive library of royalty-free bacteria, host cells, and viruses to over 100 leading international diagnostic companies for infectious disease testing. The company grows, purifies, and inactivates bacteria and viruses as a key ingredient for immunoassays to establish the presence of human antibodies. MBX is also a global leader in quality assessment and proficiency testing products used in diagnostic laboratories to meet quality objectives and requirements."

© 2020 Canjex Publishing Ltd. All rights reserved.